Africa: Bill & Melinda Gates Medical Research Institute Initiates Phase Three Clinical Trial of Tuberculosis Vaccine Candidate

1 min

Gates Foundation] A large Phase 3 trial will evaluate whether the M72/AS01E vaccine candidate can protect adolescents and adults from pulmonary tuberculosis Clinical trial site at University of the Witwatersrand, Johannesburg, South Africa, is first of up to 60 sites in seven countries The M72/AS01E vaccine candidate could be the first new TB vaccine in 100 years if proven effective…
Read More

Like it? Share with your friends!

Send this to a friend